Entering text into the input field will update the search result below

LABU Ratio Spread

Jan. 23, 2019 11:05 PM ET2 Comments
IndyDoc1 profile picture
IndyDoc1's Blog
61 Followers
Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Seeking Alpha Analyst Since 2012

self directed investor

Summary

  • Direxion Daily S&P Biotech Bull 3X Shares.
  • Double ratio spread.
  • Adjustment plans.

The strategy will test the integrity of option adjustments on this highly volatile derivative which also comes with rich premium.  LABU trades at $ 43.48 at the end of today's market. Assuming that the options were ordered right before the closing, here is the position:

Buy to open 5 contracts  1st Mar $43.00 Call at $5.5 each ( $ 2750 ).

Sell to open 5 contracts 1st Mar $50.00 Call at $2.6 each  ( $ 1300 ).

Buy to open 8 contracts 1st Mar $55.00 Call at $1.35 each  ( $ 1080 ). 

Buy to open 5 contracts 1st Mar $43.50 Put at $5.3 each  ( $ 2650 ). 

Buy to open 5 contracts 1st Mar $38.50 Put at $3.15 each  ( $ 1575 ). 

Buy to open 8 contracts 1st Mar $35.00 Put at $2.05 each  ( $ 1640 ). 

Total credit is $195 ( friction and trade costs are not included ).

The position will be at risk once the underlying approaches $55 or $35. In that case, an adjustment that include adding positive or negative delta to neutralize the short call or put respectively will be made. To fund the adjustment, a credit spread will be sold in the opposite side, either the same month or on next expiration month. 

 

Analyst's Disclosure: I am/we are long GILD.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.